Lumpkin to industry: "You're a stakeholder, not a partner"
This article was originally published in SRA
Senior US Food and Drug Administration official Murray Lumpkin moved to distance the agency from the pharmaceutical industry when he said earlier this week that the FDA “engaged” rather than collaborated with the industry and that the industry was a "stakeholder" of the agency rather than a customer or even a partner.
You may also be interested in...
The EU product information for Ibrance, Verzenios and Kisqali is being updated to include interstitial lung disease and pneumonitis. The change has already been implemented in the US.